OSTOMY MEDICAL DEVICE WITH WORLDWIDE SALES

by | Oct 22, 2025 | Active, Manufacturing, Manufacturing, Med-Tech

OSTOMY MEDICAL DEVICE WITH WORLDWIDE SALES

 
NVC2265
 

About the Company

This ostomy medical device provides comfort, ease and peace of mind to thousands of patients across the U.S. and overseas. The long-established brand name is instantly recognizable to those who need and use the device and to those medical professionals who recommend it. A Midwest-based Company manufactures and markets the trademarked and copyrighted product, which has been registered with the U.S. Food and Drug Administration since before its original introduction to the market more than 25 years ago. With its strong brand and loyal customers, the device represents a growth opportunity for a medical supply company with the resources to expand on its record of success.  

GROWTH OPPORTUNITIES

Revamped manufacturing – Taking production in-house would likely reduce the cost of bringing the product to market. 

Emphasizing sales – For major manufacturers in this space, there is a significant opportunity to increase penetration with existing channels. 

International business – While current sales are primarily in the U.S., there are established international customers that can be expanded with significant growth potential. 

INVESTMENT HIGHLIGHTS 

Established brand – The product enjoys wide name recognition among medical professionals and patients for the ease and peace of mind it brings to users. 

Adaptability – It can be easily used in conjunction with other manufacturer’s medical devices. 

Lack of competition – There is no legitimate direct competitor.  

Supplier relationships – After decades of successful sales, the product is a known commodity with nearly two dozen medical supply companies.  

MARKET OPPORTUNITY

Our device is used with an essential complementary device 

North America –  

  • Complementary device sales: 82,000,000 units annually
  • Target market share: 20%
  • Estimated units: 16,400,000
  • Total potential revenue: $16,400,000 

International – 

  • There is a significant opportunity for sales in Japan, South Korea, Australia and New Zealand as well as additional sales in Europe.
  • Combined, complementary devices sales are estimated at over 100,000,000 units annually.    

REVENUE AND EBITDA

2024 Revenue: $480,000 

2024 EBITDA: $250,000 

INTERESTED?

If this opportunity fits your Company, please fill out the below NDA to get started and contacted with more information.

 

Non-Disclosure Agreement

Contact us for more information!

NuVescor Group

(616) 379-4047 Ext: 106

MIDWEST MEDICAL DEVICE MANUFACTURING COMPANY

by | Oct 15, 2025 | Active, Manufacturing, Manufacturing, Med-Tech

Midwest Medical Device Manufacturing Company

 
NVC2265
 

About the Company

This Midwest Medical Device Manufacturing Company specializes in ultrasonic wound therapy systems and medical devices. The focus is on medical and surgical instruments, particularly for wound care, with additional product lines pending FDA clearance. Based in the Midwest with global reach, the company generates significant revenue with a low number of employees. Primary services include the design and manufacture of ultrasonic wound therapy systems and the development of medical devices for wound care. Key capabilities include expertise in ultrasonic technology for medical applications, ongoing research and development for new product lines, and compliance with regulatory standards. 

GROWTH OPPORTUNITIES

Expansion into New Markets – There is significant potential to expand into emerging markets where the prevalence of chronic wounds is increasing in regions with aging populations. 

Technological Innovations – Continued investment in research and development can lead to the creation of more advanced and effective wound care solutions.  

INVESTMENT HIGHLIGHTS 

Growing Market Demand – The global market for wound care devices is expanding, driven by the increasing prevalence of chronic wounds and the aging population.  

Market Focus – The Company’s device is primarily used for treating chronic and complex wounds, such as diabetic ulcers, pressure sores, venous ulcers, burn treatments and surgical wounds. 

Value Focused – The Company’s mission and values focus on patient solutions, improving quality care by fostering technology and creativity to anticipate emerging needs. 

REVENUE AND EBITDA

  2023 Actual  2024 Actual  2025 Forecast 
Revenue  $1,450,000  $11,340,000  $14,740,000 
EBITDA  -$170,000  $3,500,000  $4,700,000 

INTERESTED?

If this opportunity fits your Company, please fill out the below NDA to get started and contacted with more information.

 

Non-Disclosure Agreement

Contact us for more information!

NuVescor Group

(616) 379-4047 Ext: 106

MECHANICAL CONSTRUCTION AND INDUSTRIAL MRO COMPANY

by | Oct 14, 2025 | Active, Manufacturing, Manufacturing

MECHANICAL CONSTRUCTION AND INDUSTRIAL MRO COMPANY

RA220

About the Company

A well-established, full-service industrial and mechanical construction and MRO firm based in the Midwest with over 40 years of proven success. The Company delivers end-to-end solutions, including: 

  • Specialized Industrial Services – piping, rigging, millwright services, structural steel, insulation, scaffolding, and HVAC. 
  • Construction & Project Execution – spanning concept, engineering support, execution, and completion. 
  • Facility Maintenance & Operational Support – “nested” plant maintenance teams and long-term facility support agreements.  

Serving customers in the chemical, food and beverage, renewable energy, consumer goods, steel, air separation, pulp and paper, pharmaceuticals, plastics, and oil and gas end markets, the Company is driven by a seasoned leadership team and a strong operational culture. Its scalable platform benefits from a solid reputation, long-standing client relationships, and consistent performance. The Company offers attractive growth opportunities for strategic or financial buyers. 

GROWTH OPPORTUNITIES

Current Opportunities: 

  • Projected revenue of approximately $165,000,000 for the 2025 fiscal year, more than doubling since 2022. 
  • Projected backlog of $100,000,000+ secured for 2026, supporting visibility and growth. 
  • A strong focus on higher-margin projects across diverse industries. 

Strategic Initiatives: 

  • Investment in business development resources to further expand into the Southeastern U.S. 
  • Implementation of an enhanced ERP platform in order to improve project controls and efficiency. 
  • Pursuing expanded service offerings, including increased data center construction capabilities, growth in modular fabrication services, and additional long-term facility maintenance agreements. 
INVESTMENT HIGHLIGHTS 
Long-Term Excellence:  Four decades of industry leadership with a proven track record. Highly skilled team of talented, committed construction and maintenance professionals. 

Advantageous Contract Structures – Approximately 50% of 2024 and 2025 revenue has come from cost-reimbursable / NTE structures, mitigating cost overrun and project delay risks. 

Safety First – As the #1 core value, the Company’s safety culture is embedded at every organizational level, which drives client confidence and reduces operational risk. 

Maintenance & Facility Support – Approximately 15% of annual revenue comes from “nested employee” maintenance & operational agreements, enhancing client “stickiness” and providing recurring revenue. 

REVENUE AND EBITDA

  2023  2024  TTM 
Revenue  $85,000,000 $130,000,000 $170,000,000
EBITDA  $5,000,000 $8,000,000 $17,000,000

 

INTERESTED?

If this opportunity fits your Company, please fill out the below NDA to get started and contacted with more information.

 

Non-Disclosure Agreement

Contact us for more information!

NuVescor Group

(616) 379-4047 Ext: 106